Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study

Fredrik Andersson; E. Ståhl; Peter J Barnes; C.-G. Löfdahl; Paul M. O’Byrne; Ruben Pauwels; Dirkje S. Postma; Anne E. Tattersfield; A. Ullman

doi:10.1053/rmed.2001.1078

Related publications

Article2001

Adding formoterol to budesonide in moderate asthmatics is cost saving - Results from the FACET Study

E. Ståhl, Fredrik Andersson, Peter J Barnes, Claes-Göran Löfdahl, Paul M. O’Byrne, Ruben Pauwels, D.S. Postma, A. E. Tattersfield, A. Ullman

Article2018

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

Eric D. Bateman, Helen K. Reddel, Paul M. O’Byrne, Peter J Barnes, Nanshan Zhong, Christina Keen, Carin Jorup, Rosa Lamarca, Agnieszka Siwek-Posłuszna, J. Mark FitzGerald

Article2018

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman, Peter J Barnes, Nanshan Zhong, Christina Keen, Carin Jorup, Rosa Lamarca, Stefan Ivanov, Helen K. Reddel

Article2001

Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma

Paul M. O’Byrne, Peter J Barnes, Roberto Rodríguez-Roisin, E Runnerström, Thomas Sandström, Klas Svensson, Anne E. Tattersfield

Article2021

Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies

J. Mark FitzGerald, Paul M. O’Byrne, Eric D. Bateman, Peter J Barnes, Jinping Zheng, Stefan Ivanov, Rosa Lamarca, Ulrika Larsdotter, Ulrika Emerath, Gerreke Jansen, Margareta Puu, Vijay K. T. Alagappan, Filip Surmont, Helen K. Reddel